Whilst APP mutations in humans generally result in typical AD, they are predominantly linked to solely amyloid pathology in APP transgenic mice and there is no noticeable neurodegeneration [14,15], as there were no characteristic signs observed in our transgenic mice TgAPP, contrary to the WT mice (Supplementary data, Figure S1). This evidence concerns the gene APP and Alzheimer disease.